Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

Donald Trump’s tariff move impacts Indian pharma stocks. Companies like Sun Pharma, Cipla, and Dr. Reddy’s face potential declines. US represents a major market for Indian exports.

More From Author

Indian Railways revises contract conditions: Introduces localisation, price variation clauses; compliance with GST norms in focus

National Dumpling Day 2025: 6 Delicious Dumplings You Can Savour At Home

Leave a Reply